NCT01549067

Brief Summary

Collect the real clinical background of advanced colorectal cancer c of China.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2011

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 8, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

March 14, 2012

Status Verified

March 1, 2012

Enrollment Period

1.3 years

First QC Date

March 6, 2012

Last Update Submit

March 13, 2012

Conditions

Advanced Malignant NeoplasmColorectal Cancer

Keywords

AdvancedColorectal CancerTargeted chemotherapySurgeryRadiotherapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Advanced Colorectal Cancer

You may qualify if:

  • Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.

You may not qualify if:

  • Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Peking University Cancer Hospital

Beijing, Beijing Municipality, China

RECRUITING

Sun Yat-sen University Cancer Center

Zhongshan, Guangzhou, China

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Lin Shen, MD

    Peking University Cancer Hospital & Institute

    PRINCIPAL INVESTIGATOR

  • Ruihua Xu, MD, PhD

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lin Shen, MD

CONTACT

010-88140650lin100@medmail.com.cn

Rui-hua Xu, MD, PhD

CONTACT

020-87343468xurh@sysucc.org.cn

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 6, 2012

First Posted

March 8, 2012

Study Start

September 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

March 14, 2012

Record last verified: 2012-03

Locations

CN(2)